Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3981052
Max Phase: Preclinical
Molecular Formula: C31H38N6O6S
Molecular Weight: 622.75
Molecule Type: Small molecule
Associated Items:
ID: ALA3981052
Max Phase: Preclinical
Molecular Formula: C31H38N6O6S
Molecular Weight: 622.75
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(NC(=O)CCCCNC(=N)N)cc2)C(=O)O)c2ccccc12
Standard InChI: InChI=1S/C31H38N6O6S/c1-20-11-16-27(24-8-3-2-7-23(20)24)44(42,43)37-18-6-9-26(37)29(39)36-25(30(40)41)19-21-12-14-22(15-13-21)35-28(38)10-4-5-17-34-31(32)33/h2-3,7-8,11-16,25-26H,4-6,9-10,17-19H2,1H3,(H,35,38)(H,36,39)(H,40,41)(H4,32,33,34)/t25-,26-/m0/s1
Standard InChI Key: OSUIXCNIVHYKRR-UIOOFZCWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 622.75 | Molecular Weight (Monoisotopic): 622.2574 | AlogP: 2.71 | #Rotatable Bonds: 13 |
Polar Surface Area: 194.78 | Molecular Species: ZWITTERION | HBA: 6 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.33 | CX Basic pKa: 12.06 | CX LogP: 1.05 | CX LogD: 1.05 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.10 | Np Likeness Score: -0.85 |
1. Reed NI, Tang YZ, McIntosh J, Wu Y, Molnar KS, Civitavecchia A, Sheppard D, DeGrado WF, Jo H.. (2016) Exploring N-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors., 7 (10): [PMID:27774126] [10.1021/acsmedchemlett.6b00196] |
Source(1):